Beta Bionics
BBNX
18.08
-0.55
-2.95%
Beta Bionics
US · BBNX
#3406 by market cap
Listed 2025
18.08
-0.55
-2.95%
Live - 5344 symbols - heartbeat 289s ago
· 2026-10-08 09:16
Pre-market
17.85
-1.27%
After-hours
18.08
0.00%
- Market cap
- 813.41M
- P/E (TTM)i
- -11.15
- P/Bi
- 3.17
- EPSi
- -1.65
- Div yieldi
- 0.00%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on BBNX?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
William Blair Initiates Beta Bionics(BBNX.US) With Hold RatingMarket Newswire · 2026/8/21
-
Leerink Partners Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $27Market Newswire · 2026/9/17
-
Rating change
BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18Market Newswire · 2026/8/11
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Beta Bionics, Inc. (BBNX) and Pelthos Therapeutics (PTHS)TipRanks · 2026/9/15
-
Rating change
Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $25Market Newswire · 2026/9/18
-
Rating change
Lake Street Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)TipRanks · 2026/7/30
-
Rating change
Truist Financial Maintains Beta Bionics(BBNX.US) With Buy RatingMarket Newswire · 2026/9/14
-
Truist Financial Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $28Market Newswire · 2026/9/24
-
Rating change
Analysts Offer Insights on NA Companies: General Dynamics (GD), Alphabet Class A (GOOGL) and Beta Bionics, Inc. (BBNX)TipRanks · 2026/9/14
-
Rating change
Stifel Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $22Market Newswire · 2026/9/16
-
Barclays Initiates Beta Bionics(BBNX.US) With Buy Rating, Announces Target Price $30Market Newswire · 2026/10/7
-
Rating change
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $15.5 to $30.4Market Newswire · 2026/7/31
-
Beta Bionics, Inc. (BBNX) Receives a Buy From Truist FinancialTipRanks · 2026/9/24
-
Rating change
Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $25Market Newswire · 2026/9/22
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Douglas AG (OtherDOUDF) and Beta Bionics, Inc. (BBNX)TipRanks · 2026/9/18
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Lineage, Inc. (LINE), Beta Bionics, Inc. (BBNX) and Huron Consulting (HURN)TipRanks · 2026/9/14
-
Rating change
Analysts Offer Insights on NA Companies: Beta Bionics, Inc. (BBNX), Meta Platforms (META) and Turn Therapeutics Inc (TTRX)TipRanks · 2026/9/15
-
Rating change
Beta Bionics, Inc. (BBNX) Receives a Buy From Stifel NicolausTipRanks · 2026/9/16
-
Wells Fargo Initiates Beta Bionics(BBNX.US) With Buy Rating, Announces Target Price $28Market Newswire · 2026/9/23
-
Rating change
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $18 to $27Market Newswire · 2026/9/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:16:15 · For reference only, not investment advice and not tailored to your situation.